COJOCARU, S., РУСУ, И., BUTA, G., BERSAN, S., POTÎNG-RAȘCOV, V., CULIUC, N. и BABA, L. (2023) «A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease», One Health & Risk Management , 4(4), сс. 19-26. doi: 10.38045/ohrm.2023.4.02.